P360 is a sample vendor in Gartner® Hype Cycle™ 2022 report
Brian Fitzgerald | August 22, 2022
P360 is proud to announce they have been featured in Gartner’s1 Hype Cycle for Life Science Commercial Operations, 2022 released this summer. P360 was listed in both the Life Science Sales Performance Management (LSSPM) and Chatbots in Life Sciences categories. As per the annual report, Life Science Sales Performance Management (LSSPM) is “a suite of operational and analytical functions that automate and unite sales planning and operational sales processes.” And Chatbots in Life Sciences is defined as “text- or voice-based technologies that enable human-like interactions between life science organizations and healthcare stakeholders at scale.”
The 2022 Gartner® Hype Cycle™ for Life Science Commercial Operations acts as an in depth guide for organizations seeking new technologies and innovations for integration within their ecosphere to amplify their go-to-market strategies and support their overall growth. This yearly report is often looked at by many organizations as a road map of innovative and growing technologies and companies that have a strong value add to the life science sector and beyond.
P360’s powerful data management and analytics platform BirdzAI is the perfect example of what an LSSPM solution is comprised of. The robust yet flexible solution enables life sciences companies to have a state-of-the-art Master Data Management ecosystem. And the platform’s advanced machine learning algorithms turn that siloed data into insights for real-time sales operations decision-making and forecasting for planning appropriately. This includes sales forecasting, brand propensity analysis, next best action insights and more that can take a company’s sales planning to the next level.
Amid a climate of increased regulations, escalating costs, and ever-changing policies, pharmaceutical companies are investing more and more into their digital transformation. Every aspect of their business workflow is being scrutinized from research and development to marketing and branding. For pharmaceutical sales operations, this shift in thinking means focusing on enhancing health care provider (HCP) engagement in a more meaningful, reliable way while maintaining compliance regulations no matter the communication. With BirdzAI, pharmaceutical companies can automate their pharma marketing while optimizing their sales operations and utilizing discontinuous streams of data from one robust, scalable solution all while maintaining regulatory oversight.
“BirdzAI enables life sciences companies to manage their business processes and data from a single platform, eliminating manual work and operational delays,” stated P360 CEO and Founder Anupam Nandwana. “It is the most comprehensive LSSPM solution available. However, it is also extremely flexible and customizable. When needed, it easily integrates with other CRM, sales enablement, and data solutions.”
The BirdzAI platform also offers unique functionality for companies launching new drugs into the marketplace. Key features and tested processes include customer alignment, customer master data management, territory planning and sizing, call planning, incentive compensation strategy and payout, roster management and field and management reporting. With integrated Artificial Intelligence (AI) and Machine Learning (ML), the BirdzAI platform is able to ingest and process siloed data sources, aggregate said data into a usable whole data lake of knowledge, and apply integrations as necessary for usable implementations.
Rounding out Gartner’s Chatbots in Life Sciences category is the ZING Engagement Suite. This innovative suite of technologies is a comprehensive and compliant solution that enhances existing communication channels with features including text message-based Chatbot assistance, live SMS messaging, onscreen collaboration and form sharing, inbound communications with QR code scan, signature capture, easy access integrations and more. The ZING Engagement Suite offers a scalable, easily integrated solution for better, faster HCP engagement with no app or login needed, making pharma communications more accessible and timely.
“The ZING Engagement Suite is the only platform available that equips pharmaceutical sales and marketing teams with everything they need to engage in compliant communication with healthcare professionals on their mobile devices,” stated Nandwana. “And ZING’s chatbot functionality is a key part of the compliance equation. With it, messages with HCPs can be preapproved, preloaded, and automatically responded to.”
The recently relaunched expanded ZING Engagement Suite is the next gen of P360’s previously announced ZING Communication Module. Boasting an expanded enterprise-grade feature set, ZING is a robust unified communications as a service (UCaaS) platform that empowers pharmaceutical sales teams to connect in a more meaningful and immediate way with healthcare professionals in a multitude of ways.
The ZING Engagement Suite enables personalized 1:1 communication using native text messaging on a HCPs iOS or Android device with pre-built integrations with major CRMs. This makes it easy for pharma IT teams in terms of data management and integrity for things like territory alignments, roster changes and other specific data integration needs. Compliance can track every communication, end-to-end. And managers can measure activity and results with ZING’s powerful dashboards.
Explore More Relevant Articles on P360
- What Pharma Needs to Know About 2022’s Top Tech Trends
- How AI Is Elevating the Pharma Industry
- 6 Reasons Why Pharma 3.0 Is Your Path to Commercial Success
- Technology Is the Key to a More Holistic Customer Experience in Pharma
To learn more about P360 and all its innovative solutions, visit P360.com.
Gartner, “Hype Cycle for Life Science Commercial Operations,” Animesh Gandhi, July 18, 2022.